Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Head & Face Medicine
Published in: Head & Face Medicine 1/2008

Open Access 01-12-2008 | Review

The use of botulinum toxin in head and face medicine: An interdisciplinary field

Author: Rainer Laskawi

Published in: Head & Face Medicine | Issue 1/2008

Login to get access

Abstract

Background

In this review article different interdisciplinary relevant applications of botulinum toxin type A (BTA) in the head and face region are demonstrated.
Patients with head and face disorders of different etiology often suffer from disorders concerning their musculature (example: synkinesis in mimic muscles) or gland-secretion.
This leads to many problems and reduces their quality of life. The application of BTA can improve movement disorders like blepharospasm, hemifacial spasm, synkinesis following defective healing of the facial nerve, palatal tremor, severe bruxism, oromandibular dystonias hypertrophy of the masseter muscle and disorders of the autonomous nerve system like hypersalivation, hyperlacrimation, pathological sweating and intrinsic rhinitis.

Conclusion

The application of botulinum toxin type A is a helpful and minimally invasive treatment option to improve the quality of life in patients with head and face disorders of different quality and etiology. Side effects are rare.
Appendix
Available only for authorised users
Literature
1.
Kerner J: Vergiftung durch verdorbene Würste. Tübinger Blätter f Naturwissensch u Arzneykunde. 1817, 3: 1-25.
2.
Van Ermengem E: Über eine neuen anaeroben Bacillus und seine Beziehungen zum Botulismus. Z Hyg Infektionskrankh. 1897, 26: 1-56.
3.
Scott AB: Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Opthalmol. 1980, 87 (10): 1044-1049.CrossRef
4.
5.
Merte RL, Lanzl IM: Botulinum toxin injection for production of ptosis. Ophthalmologe. 2007, 104: 767-770.CrossRefPubMed
6.
7.
Laskawi R, Damenz W, Roggenkämper P, Baetz A: Botulinum toxin treatment in patients with facial synkinesis. Eur Arch Otorhinolaryngol. 1994, 195-199. Suppl
8.
Roggenkämper P, Laskawi R, Damenz W, Schröder M, Nüßgens Z: Orbicular synkinesis after facial paralysis: treatment with botulinum toxin. Documenta Ophthalmologica. 1994, 86: 395-402.CrossRefPubMed
9.
Laskawi R: Combination of hypoglossal-facial nerve anastomosis and botulinum toxin injections to optimize mimic rehabilitation following removal of acoustic neurinomas. Plast Reconstr Surg. 1997, 99: 1006-1011.CrossRefPubMed
10.
Laskawi R, Rohrbach S, Rödel R: Surgical and nonsurgical treatment options in patients with movement disorders of the platysma. J Oral Maxillofac Surg. 2002, 60: 157-162.CrossRefPubMed
11.
Laskawi R, Rohrbach S: Surgical and conservative methods for restoring impaired motor function: facial nerve, spinal accessory nerve, hypoglossal nerve (not including vagal nerve or swallowing). GMS Curr Top Otorhinolaryngol Head Neck Surg. 2005, 4: Doc 10
12.
Gassner HG, Brissett Ae, Otley CC, Boahene DK, Biggust AJ, Weaver AL, Sherris DA: Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study. Mayo Clin Proc. 2006, 81: 1023-1028.CrossRefPubMed
13.
Dastoor SF, Misch CE, Wang HL: Botulinum toxin (Botox) to enhance facial macroesthetics: a literature review. J Oral Implantol. 2007, 33: 164-71.CrossRefPubMed
14.
Samton J, Mauskop A: Treatment of headaches with botulinum toxin. Expert Rev Neurother. 2006, 6: 313-22.CrossRefPubMed
15.
Junghans K, Rohrbach S, Ellies M, Laskawi R: Improvement of chronic facial pain and facial dyskinesia with the help of botulinum toxin application. Head Face Med. 2007, 3: 32-CrossRefPubMedPubMedCentral
16.
Penney SE, Bruce IA, Saeed SR: Botulinum toxin is effective and safe for palatal tremor: a report of five cases and a review of the literature. J Neurol. 2006, 253: 857-60.CrossRefPubMed
17.
Olthoff A, Laskawi R, Kruse E: Successful treatment of autophonia with botulinum toxin: case report. Ann Otol Rhinol Laryngol. 2007, 116: 594-8.CrossRefPubMed
18.
Laskawi R, Rohrbach S: Oromandibular dystonia. Clinical forms, diagnosis and examples of therapy with botulinum toxin. Laryngorhinootologie. 2001, 80: 708-13.CrossRefPubMed
19.
Clark GT, Ram S: Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions. Dent Clin North Am. 2007, 51: 225-43.CrossRefPubMed
20.
Arikan OK, Tan FU, Kendi T, Koc C: Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy. J Otolaryngol. 2006, 35: 40-3.CrossRefPubMed
21.
Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R: Reduction of Salivary Flow with Botulinum Toxin: Extended Report on 33 Patients with Drooling, Salivary Fistulas and Sialadenitis. Laryngoscope. 2004, 114: 1856-1860.CrossRefPubMed
22.
Benson J, Daugherty KK: Botulinum toxin A in the treatment of sialorrhea. Ann Pharmacother. 2007, 41: 79-85.CrossRefPubMed
23.
Drobik C, Laskawi R: Frey Syndrom: Therapie mit Botulinum-Toxin. HNO aktuell. 1994, 2: 142-144.
24.
Laskawi R, Drobik C, Schönebeck C: Up-to-date report of botulinum toxin treatment in patients with gustatory sweating. Laryngoscope. 1998, 108: 381-384.CrossRefPubMed
25.
Laskawi R, Ellies M, Rödel R, Schoenebeck C: Gustatory sweating – Clinical implications and etiologic aspects. J Oral Maxillofac Surg. 1999, 57: 642-648.CrossRefPubMed
26.
Laskawi R, Rohrbach S: Treatment of gustatory sweating with botulinum toxin: Special aspects. ORL. 2001, 63: 294-297.CrossRefPubMed
27.
Laskawi R, Rohrbach S: Frey's syndrome: treatment with botulinum toxin. Hyperhidrosis and botulinum toxin in dermatology. Edited by: Kreyden OP, Böni R, Burg G. 2002, Curr Probl Dermatol, Basel, Karger, 30: 170-177.CrossRef
28.
Glaser DA: The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome. Neurotox Res. 2006, 9: 173-177.CrossRefPubMed
29.
Meyer M: Störungen der Tränendrüsen. Botulinumtoxintherapie im Kopf-Hals-Bereich. Edited by: Laskawi R, Roggenkämper P. 2004, Urban und Vogel, München, 313-322.
30.
Riemann R, Pfenningsdorf S, Riemann E, Naumann M: Successful treatment of crocodile tears by injection of botulinum toxin into lacrimal gland: a case report. Ophthalmology. 1999, 106: 2322-2324.CrossRefPubMed
31.
Whittaker KW, Matthews BN, Fitt AW, Sandramouli S: The use of botulinum toxin A in the treatment of functional epiphora. Orbit. 2003, 22: 193-198.CrossRefPubMed
32.
Özcan C, Vayisoglu Y, Dogu O, Görür K: The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol. 2006, 27: 314-8.CrossRefPubMed
33.
Rohrbach S, Olthoff A, Laskawi R, Giefer B, Götz W: Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol. 2001, 110: 1045-50.CrossRefPubMed
34.
Rohrbach S, Laskawi R: Minimally invasive application of botulinum toxin type A in nasal hypersecretion. ORL J Otorhinolaryngol Relat Spec. 2001, 63: 382-4.CrossRefPubMed
35.
Laskawi R: Botulinum toxin treatment in the head and neck region: current aspects, developments, and problems. HNO. 2007, 55: 437-442.CrossRefPubMed
36.
Stidham KR, Solomon PH, Robersson JB: Evaluation of botulinum toxin A treatment of tinnitus. Otolaryngol Head Neck Surg. 2005, 132: 883-889.CrossRefPubMed
37.
Finzi E, Wasserman E: Treatment of depression with botulinum toxin A: a case series. Dermatol Surg. 2006, 32: 645-649.PubMed
Metadata
Title
The use of botulinum toxin in head and face medicine: An interdisciplinary field
Author
Rainer Laskawi
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Head & Face Medicine / Issue 1/2008
Electronic ISSN: 1746-160X
DOI
https://doi.org/10.1186/1746-160X-4-5

Other articles of this Issue 1/2008

Head & Face Medicine 1/2008 Go to the issue

Case report

Ectopic internal carotid artery presenting as an oropharyngeal mass

Case Study

Perioperative and long-term operative outcomes after surgery for trigeminal neuralgia: microvascular decompression vs percutaneous balloon ablation

Research

In vitro evaluation of various bioabsorbable and nonresorbable barrier membranes for guided tissue regeneration

Research

In vitro behaviour of endothelial cells on a titanium surface

Research

Osseointegration of zirconia implants compared with titanium: an in vivo study

Research

The role of apoptosis in early embryonic development of the adenohypophysis in rats